Issue 7, 2015

Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicines

Abstract

This review highlights a unique research area in polymer-based nanomedicine designs. Drug-free macromolecular therapeutics induce apoptosis of malignant cells by the crosslinking of surface non-internalizing receptors. The receptor crosslinking is mediated by the biorecognition of high-fidelity natural binding motifs (such as antiparallel coiled-coil peptides or complementary oligonucleotides) that are grafted to the side chains of polymers or attached to targeting moieties against cell receptors. This approach features the absence of low-molecular-weight cytotoxic compounds. Here, we summarize the rationales, different designs, and advantages of drug-free macromolecular therapeutics. Recent developments of novel therapeutic systems for B-cell lymphomas are discussed, as well as relevant approaches for other diseases. We conclude by pointing out various potential future directions in this exciting new field.

Graphical abstract: Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicines

Article information

Article type
Review Article
Submitted
18 Dec 2014
Accepted
26 Jan 2015
First published
05 Feb 2015

Biomater. Sci., 2015,3, 908-922

Author version available

Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicines

T. Chu and J. Kopeček, Biomater. Sci., 2015, 3, 908 DOI: 10.1039/C4BM00442F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements